Nanoplasmid™ System Bibliography Of Publications

The Nanoplasmid™ vector is small plasmid backbone (<500 bp) that is designed to replace antiquated bacterial backbones that have been the industry standard in DNA vectors for decades. Its size is the key to many performance benefits across a variety of cell and gene therapy applications. Nanoplasmids can be use directly such as in non-viral gene therapy and DNA vaccine applications or indirectly as transposons, CRISPR HDR vectors, viral vectors, and mRNA vectors. Explore the publications that spotlight some of the performance benefits of the Nanoplasmid platform.